Clin2
NCT07174414Possibly a fitNot yet recruiting

Cilostazol to prevent another stroke

Stroke RecurrenceMyocardial InfarctionVascular DeathIschemic StrokeTIA (Transient Ischemic Attack)Stroke (CVA) or Transient Ischemic AttackRecurrent Stroke

Treatments studied

Part of Brain & nervous system, Heart & circulation clinical trials.

This trial tests a drug called cilostazol to see if it can help prevent a second stroke or mini-stroke. You may be a candidate if you have had a stroke or mini-stroke in the past 6 months and are already taking one blood thinner (aspirin or clopidogrel), but not both.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
2,000 people
Ages
40 years and older
Study type
Interventional

Who can take part

  • You had a stroke or mini-stroke (TIA) within the last 6 months.
  • You are currently taking aspirin or clopidogrel (but not both) to lower your stroke risk.
  • You have not had a spontaneous brain bleed in the last 2 years.
  • You do not have moderate to severe heart failure.
  • Your doctor expects you to live longer than 6 months.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06591351Recruiting· Phase 3
Aspirin plus cilostazol or clopidogrel for minor stroke or TIA

This trial tests whether adding cilostazol or clopidogrel to aspirin is safe and effective for people who recently had a mild stroke or a transient ischemic attack (TIA) caused by a large artery blockage. It aims to prevent another stroke during the first 90 days.

Kafr ash Shaykh
NCT06591299Recruiting· Phase 3
Aspirin plus cilostazol or clopidogrel for minor stroke or TIA

This trial is testing whether combining aspirin with either cilostazol or clopidogrel is more effective at preventing another stroke after a minor stroke or TIA. It is for people who had their first mild stroke or TIA and started a blood thinner within 24 hours.

Kafr ash Shaykh
NCT06561867Recruiting· Phase 3
Comparing two drugs to prevent another stroke

This trial tests if ticagrelor or cilostazol is better at preventing a second stroke in people who have had their first mild to moderate ischemic stroke. It aims to find which treatment works best within the first 24 hours of symptoms.

Kafr ash Shaykh
NCT06196047Recruiting· Phase 3
Ticagrelor vs cilostazol for minor stroke or TIA

This study compares two blood thinner medicines, ticagrelor and cilostazol, to see which is better at preventing another stroke in people who have just had a minor stroke or TIA (a mini-stroke). It is for people who started treatment within 24 hours of their symptoms.

Kafr ash Shaykh
NCT06591390Recruiting· Phase 3
Aspirin plus another drug for minor stroke or TIA

This trial tests whether taking aspirin along with either ticagrelor or cilostazol helps prevent another stroke in people who have had a mild stroke or transient ischemic attack (mini-stroke). You must start treatment within 24 hours of your first symptoms.

Kafr ash Shaykh
NCT06591377Recruiting· Phase 3
Aspirin plus a second drug for minor stroke or TIA

This trial tests whether adding ticagrelor or cilostazol to aspirin is better than aspirin alone for preventing another stroke. It is for patients who recently had a minor stroke or a transient ischemic attack (TIA) caused by a blockage in a large artery.

Cairo

Hear when a new Stroke Recurrence trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.